ERBB2 c.2305G>T ;(p.D769Y)

Variant ID: 17-37880261-G-T

NM_004448.2(ERBB2):c.2305G>T;(p.D769Y)

This variant was identified in 152 publications

View GRCh38 version.




Publications:


Workflow enabling deepscale immunopeptidome, proteome, ubiquitylome, phosphoproteome, and acetylome analyses of sample-limited tissues.

Nature Communications
Abelin, Jennifer G JG; Bergstrom, Erik J EJ; Rivera, Keith D KD; Taylor, Hannah B HB; Klaeger, Susan S; Xu, Charles C; Verzani, Eva K EK; Jackson White, C C; Woldemichael, Hilina B HB; Virshup, Maya M; Olive, Meagan E ME; Maynard, Myranda M; Vartany, Stephanie A SA; Allen, Joseph D JD; Phulphagar, Kshiti K; Harry Kane, M M; Rachimi, Suzanna S; Mani, D R DR; Gillette, Michael A MA; Satpathy, Shankha S; Clauser, Karl R KR; Udeshi, Namrata D ND; Carr, Steven A SA
Publication Date: 2023-04-03

Variant appearance in text: ERBB2: D769Y
PubMed Link: 37012232
Variant Present in the following documents:
  • 41467_2023_37547_MOESM10_ESM.xlsx, sheet 2
  • 41467_2023_37547_MOESM12_ESM.xlsx, sheet 2
  • 41467_2023_37547_MOESM10_ESM.xlsx, sheet 3
  • 41467_2023_37547_MOESM10_ESM.xlsx, sheet 4
  • 41467_2023_37547_MOESM12_ESM.xlsx, sheet 3
View BVdb publication page



Subtyping-based platform guides precision medicine for heavily pretreated metastatic triple-negative breast cancer: The FUTURE phase II umbrella clinical trial.

Cell Research
Liu, Yin Y; Zhu, Xiu-Zhi XZ; Xiao, Yi Y; Wu, Song-Yang SY; Zuo, Wen-Jia WJ; Yu, Qiang Q; Cao, A-Yong AY; Li, Jun-Jie JJ; Yu, Ke-Da KD; Liu, Guang-Yu GY; Wu, Jiong J; Sun, Tao T; Cui, Jiu-Wei JW; Lv, Zheng Z; Li, Hui-Ping HP; Zhu, Xiao-Yu XY; Jiang, Yi-Zhou YZ; Wang, Zhong-Hua ZH; Shao, Zhi-Ming ZM
Publication Date: 2023-03-27

Variant appearance in text: ERBB2: D769Y
PubMed Link: 36973538
Variant Present in the following documents:
  • Main text
  • 41422_2023_Article_795.pdf
  • 41422_2023_795_MOESM1_ESM.pdf
View BVdb publication page



Unlocking the Resistance to Anti-HER2 Treatments in Breast Cancer: The Issue of HER2 Spatial Distribution.

Cancers
Giugliano, Federica F; Carnevale Schianca, Ambra A; Corti, Chiara C; Ivanova, Mariia M; Bianco, Nadia N; Dellapasqua, Silvia S; Criscitiello, Carmen C; Fusco, Nicola N; Curigliano, Giuseppe G; Munzone, Elisabetta E
Publication Date: 2023-02-22

Variant appearance in text: HER2: D769Y
PubMed Link: 36900178
Variant Present in the following documents:
  • Main text
  • cancers-15-01385.pdf
View BVdb publication page



Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers.

Nature Communications
Harding, James J JJ; Piha-Paul, Sarina A SA; Shah, Ronak H RH; Murphy, Jessica J JJ; Cleary, James M JM; Shapiro, Geoffrey I GI; Quinn, David I DI; Braña, Irene I; Moreno, Victor V; Borad, Mitesh M; Loi, Sherene S; Spanggaard, Iben I; Park, Haeseong H; Ford, James M JM; Arnedos, Mónica M; Stemmer, Salomon M SM; de la Fouchardiere, Christelle C; Fountzilas, Christos C; Zhang, Jie J; DiPrimeo, Daniel D; Savin, Casey C; Duygu Selcuklu, S S; Berger, Michael F MF; Eli, Lisa D LD; Meric-Bernstam, Funda F; Jhaveri, Komal K; Solit, David B DB; Abou-Alfa, Ghassan K GK
Publication Date: 2023-02-06

Variant appearance in text: ERBB2: D769Y
PubMed Link: 36746967
Variant Present in the following documents:
  • 41467_2023_36399_MOESM3_ESM.xlsx, sheet 5
  • 41467_2023_36399_MOESM1_ESM.pdf
View BVdb publication page



Investigation of the prevalence and clinical implications of ERBB2 exon 16 skipping mutations in Chinese pan-cancer patients.

Frontiers In Oncology
Shang, Yanhong Y; Mo, Jianming J; Huo, Ran R; Li, Xiaofang X; Fang, Guotao G; Wei, Zichun Z; Gu, Guomin G; Zhu, Xiaodan X; Zhang, Chan C; Liu, Chunling C; Yan, Dong D
Publication Date: 2022

Variant appearance in text: ERBB2: D769Y
PubMed Link: 36686783
Variant Present in the following documents:
  • Main text
  • fonc-12-1064598.pdf
View BVdb publication page



Mechanisms of neratinib resistance in HER2-mutant metastatic breast cancer.

Cancer Drug Resistance (Alhambra, Calif.)
Eli, Lisa D LD; Kavuri, Shyam M SM
Publication Date: 2022

Variant appearance in text: HER2: D769Y
PubMed Link: 36627899
Variant Present in the following documents:
  • cdr-5-4-873.pdf
View BVdb publication page



Development of a Novel NGS Methodology for Ultrasensitive Circulating Tumor DNA Detection as a Tool for Early-Stage Breast Cancer Diagnosis.

International Journal Of Molecular Sciences
Jiménez-Rodríguez, Begoña B; Alba-Bernal, Alfonso A; López-López, Esperanza E; Quirós-Ortega, María Elena ME; Carbajosa, Guillermo G; Garrido-Aranda, Alicia A; Álvarez, Martina M; Godoy-Ortiz, Ana A; Queipo-Ortuño, María Isabel MI; Vicioso, Luis L; Díaz-Córdoba, Gema G; Roldán-Díaz, María Dunia MD; Velasco-Suelto, Jesús J; Hernando, Cristina C; Bermejo, Begoña B; Julve-Parreño, Ana A; Lluch, Ana A; Pascual, Javier J; Comino-Méndez, Iñaki I; Alba, Emilio E
Publication Date: 2022-12-21

Variant appearance in text: ERBB2: D769Y
PubMed Link: 36613590
Variant Present in the following documents:
  • ijms-24-00146.pdf
View BVdb publication page



Trastuzumab combined with irinotecan in patients with HER2-positive metastatic colorectal cancer: A phase II single-arm study and exploratory biomarker analysis.

Cancer Research And Treatment
Xu, Ting T; Wang, Xicheng X; Xin, Ying Y; Wang, Zhenghang Z; Gong, Jifang J; Zhang, Xiaotian X; Li, Yanyan Y; Ji, Congcong C; Sun, Yu Y; Zhao, Feilong F; Huang, Depei D; Bai, Yuezong Y; Li, Jian J; Shen, Lin L
Publication Date: 2022-12-23

Variant appearance in text: HER2: D769Y
PubMed Link: 36550683
Variant Present in the following documents:
  • Main text
  • crt-2022-1058.pdf
View BVdb publication page



Systematic assessment and optimizing algorithm of tumor mutational burden calculation and their implications in clinical decision-making.

Frontiers In Oncology
Sun, Daqiang D; Xu, Meilin M; Pan, Chaohu C; Tang, Hongzhen H; Wang, Peng P; Wu, Dongfang D; Luo, Haitao H
Publication Date: 2022

Variant appearance in text: ERBB2: 2305G>T
PubMed Link: 36425562
Variant Present in the following documents:
  • Table_5.xlsx, sheet 1
  • Table_4.xlsx, sheet 1
  • Table_3.xlsx, sheet 1
View BVdb publication page



Somatic mutation distribution across tumour cohorts provides a signal for positive selection in cancer.

Nature Communications
Boström, Martin M; Larsson, Erik E
Publication Date: 2022-11-17

Variant appearance in text: ERBB2: D769Y
PubMed Link: 36396655
Variant Present in the following documents:
  • 41467_2022_34746_MOESM10_ESM.xlsx, sheet 1
View BVdb publication page



Genomic landscape, immune characteristics and prognostic mutation signature of cervical cancer in China.

Bmc Medical Genomics
Liu, Jing J; Li, Zirong Z; Lu, Ting T; Pan, Junping J; Li, Li L; Song, Yanwen Y; Hu, Dan D; Zhuo, Yanhong Y; Chen, Ying Y; Xu, Qin Q
Publication Date: 2022-11-04

Variant appearance in text: ERBB2: 2305G>T; D769Y; rs121913468
PubMed Link: 36333792
Variant Present in the following documents:
  • 12920_2022_1376_MOESM1_ESM.xlsx, sheet 1
View BVdb publication page



A Case of Sustained Tumor Regression With MP0274, a Novel DARPin Therapeutic Targeting Human Epidermal Growth Factor Receptor 2 Signaling, in Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer After Prior Trastuzumab and Pertuzumab.

Jco Precision Oncology
Fischer, Stefanie S; Götze, Thorsten O TO; Omlin, Aurelius A; Baird, Richard D RD; Dawson, Keith M KM; Zitt, Christof C; Arany, Zita Z; Tresch, Gaby G; Fiedler, Ulrike U; Jeger, Simone S; Fung, Samson S; Legenne, Philippe P; Leupin, Nicolas N; Schneeweiss, Andreas A; Fremd, Carlo C
Publication Date: 2022-11

Variant appearance in text: HER2: D769Y
PubMed Link: 36331248
Variant Present in the following documents:
  • po-6-e2200006.pdf
View BVdb publication page



A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primary.

The Journal Of Pathology
Posner, Atara A; Prall, Owen Wj OW; Sivakumaran, Tharani T; Etemadamoghadam, Dariush D; Thio, Niko N; Pattison, Andrew A; Balachander, Shiva S; Fisher, Krista K; Webb, Samantha S; Wood, Colin C; DeFazio, Anna A; Wilcken, Nicholas N; Gao, Bo B; Karapetis, Christos S CS; Singh, Madhu M; Collins, Ian M IM; Richardson, Gary G; Steer, Christopher C; Warren, Mark M; Karanth, Narayan N; Wright, Gavin G; Williams, Scott S; George, Joshy J; Hicks, Rodney J RJ; Boussioutas, Alex A; Gill, Anthony J AJ; Solomon, Benjamin J BJ; Xu, Huiling H; Fellowes, Andrew A; Fox, Stephen B SB; Schofield, Penelope P; Bowtell, David D; Mileshkin, Linda L; Tothill, Richard W RW
Publication Date: 2022-10-26

Variant appearance in text: ERBB2: Asp769Tyr
PubMed Link: 36287571
Variant Present in the following documents:
  • PATH-259-81-s009.xlsx, sheet 2
View BVdb publication page



A single arm phase Ib/II trial of first-line pembrolizumab, trastuzumab and chemotherapy for advanced HER2-positive gastric cancer.

Nature Communications
Lee, Choong-Kun CK; Rha, Sun Young SY; Kim, Hyo Song HS; Jung, Minkyu M; Kang, Beodeul B; Che, Jingmin J; Kwon, Woo Sun WS; Park, Sejung S; Bae, Woo Kyun WK; Koo, Dong-Hoe DH; Shin, Su-Jin SJ; Kim, Hyunki H; Jeung, Hei-Cheul HC; Zang, Dae Young DY; Lee, Sang Kil SK; Nam, Chung Mo CM; Chung, Hyun Cheol HC
Publication Date: 2022-10-12

Variant appearance in text: ERBB2: D769Y
PubMed Link: 36224176
Variant Present in the following documents:
  • Main text
  • 41467_2022_Article_33267.pdf
View BVdb publication page



The mutational landscape of cancer's vulnerability to ionizing radiation.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Gopal, Priyanka P; Yard, Brian D BD; Petty, Aaron A; Lal, Jessica C JC; Bera, Titas K TK; Hoang, Trung Q TQ; Buhimschi, Alexandru B AB; Abazeed, Mohamed E ME
Publication Date: 2022-10-12

Variant appearance in text: ERBB2: D769Y
PubMed Link: 36222846
Variant Present in the following documents:
  • ccr-22-1914_supplementary_data_3_suppds3.xlsx, sheet 1
  • ccr-22-1914_supplementary_data_2_suppds2.xlsx, sheet 1
View BVdb publication page



The circulating tumor DNA (ctDNA) alteration level predicts therapeutic response in metastatic breast cancer: Novel prognostic indexes based on ctDNA.

Breast (Edinburgh, Scotland)
Liu, Binliang B; Hu, Zheyu Z; Ran, Jialu J; Xie, Ning N; Tian, Can C; Tang, Yu Y; Ouyang, Quchang Q
Publication Date: 2022-10

Variant appearance in text: ERBB2: D769Y
PubMed Link: 35926241
Variant Present in the following documents:
  • mmc1.xlsx, sheet 1
View BVdb publication page



Molecular Landscape of ERBB2 Alterations in 14,956 Solid Tumors.

Pathology Oncology Research : Por
Wang, Hao H; Miao, Ji J; Wen, Yazhou Y; Xia, Xihua X; Chen, Yanan Y; Huang, Mengli M; Chen, Shiqing S; Zhao, Zhengyi Z; Zhang, Yuzi Y; Chen, Chunzhu C; Zhu, Xinhua X
Publication Date: 2022

Variant appearance in text: ERBB2: D769Y
PubMed Link: 35911441
Variant Present in the following documents:
  • Main text
  • pore-28-1610360.pdf
View BVdb publication page



Genomic and epigenomic profiles distinguish pulmonary enteric adenocarcinoma from lung metastatic colorectal cancer.

Ebiomedicine
Zuo, Ying Y; Zhong, Jia J; Bai, Hua H; Xu, Bin B; Wang, Zhijie Z; Li, Weihua W; Chen, Yedan Y; Jin, Shi S; Wang, Shuhang S; Wang, Xin X; Wan, Rui R; Xu, Jiachen J; Fei, Kailun K; Han, Jiefei J; Yang, Zhenlin Z; Bao, Hua H; Shao, Yang Y; Ying, Jianming J; Song, Qibin Q; Duan, Jianchun J; Wang, Jie J
Publication Date: 2022-08

Variant appearance in text: ERBB2: D769Y
PubMed Link: 35901658
Variant Present in the following documents:
  • Main text
  • main.pdf
View BVdb publication page



ERBB2 mutation is associated with sustained tumor cell proliferation after short-term preoperative endocrine therapy in early lobular breast cancer.

Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc
Grote, Isabel I; Bartels, Stephan S; Christgen, Henriette H; Radner, Martin M; Gronewold, Malte M; Kandt, Leonie L; Raap, Mieke M; Lehmann, Ulrich U; Gluz, Oleg O; Graeser, Monika M; Kuemmel, Sherko S; Nitz, Ulrike U; Harbeck, Nadia N; Kreipe, Hans H; Christgen, Matthias M
Publication Date: 2022-12

Variant appearance in text: ERBB2: D769Y
PubMed Link: 35842479
Variant Present in the following documents:
  • 41379_2022_1130_MOESM1_ESM.pdf
View BVdb publication page



Scalable multiplex co-fractionation/mass spectrometry platform for accelerated protein interactome discovery.

Nature Communications
Havugimana, Pierre C PC; Goel, Raghuveera Kumar RK; Phanse, Sadhna S; Youssef, Ahmed A; Padhorny, Dzmitry D; Kotelnikov, Sergei S; Kozakov, Dima D; Emili, Andrew A
Publication Date: 2022-07-13

Variant appearance in text: ERBB2: 2305G>T; D769Y
PubMed Link: 35831314
Variant Present in the following documents:
  • 41467_2022_31809_MOESM8_ESM.xlsx, sheet 3
View BVdb publication page



Genetic Panel Test of Double Cancer of Signet-Ring Cell/Histiocytoid Carcinoma of the Eyelid and Papillary Thyroid Carcinoma: Case Report and Literature Review.

Cureus
Kuroki, Masashi M; Shibata, Hirofumi H; Kuze, Bunya B; Ohashi, Toshimitsu T; Kohyama, Keishi K; Kato, Hisakazu H; Kato, Hiroki H; Miyazaki, Tatsuhiko T; Tomita, Hiroyuki H; Ogawa, Takenori T
Publication Date: 2022-05

Variant appearance in text: ERBB2: D769Y
PubMed Link: 35747011
Variant Present in the following documents:
  • Main text
  • cureus-0014-00000025192.pdf
View BVdb publication page



Poziotinib Inhibits HER2-Mutant-Driven Therapeutic Resistance and Multiorgan Metastasis in Breast Cancer.

Cancer Research
Kalra, Rashi R; Chen, Ching Hui CH; Wang, Junkai J; Salam, Ahmad Bin AB; Dobrolecki, Lacey E LE; Lewis, Alaina A; Sallas, Christina C; Yates, Clayton C CC; Gutierrez, Carolina C; Karanam, Balasubramanyam B; Anurag, Meenakshi M; Lim, Bora B; Ellis, Matthew J MJ; Kavuri, Shyam M SM
Publication Date: 2022-08-16

Variant appearance in text: HER2: D769Y
PubMed Link: 35736563
Variant Present in the following documents:
  • can-21-3106_supplementary_data_suppst1.xlsx, sheet 2
View BVdb publication page



Construction and validation of an immunoediting-based optimized neoantigen load (ioTNL) model to predict the response and prognosis of immune checkpoint therapy in various cancers.

Aging
Su, Xiaofan X; Jin, Haoxuan H; Wang, Jiaqian J; Lu, Huiping H; Gu, Tiantian T; Gao, Zhibo Z; Li, Manxiang M
Publication Date: 2022-05-25

Variant appearance in text: ERBB2: 2305G>T; D769Y
PubMed Link: 35613927
Variant Present in the following documents:
  • aging-14-204101-s004.xlsx, sheet 1
View BVdb publication page



A novel treatment strategy of HER2-targeted therapy in combination with Everolimus for HR+/HER2- advanced breast cancer patients with HER2 mutations.

Translational Oncology
Ma, Jing J; Li, Xuelu X; Zhang, Qianran Q; Li, Ning N; Sun, Siwen S; Zhao, Shanshan S; Zhao, Zuowei Z; Li, Man M
Publication Date: 2022-07

Variant appearance in text: HER2: D769Y
PubMed Link: 35523006
Variant Present in the following documents:
  • Main text
  • main.pdf
View BVdb publication page



Computational and Functional Analyses of HER2 Mutations Reveal Allosteric Activation Mechanisms and Altered Pharmacologic Effects.

Cancer Research
Ishiyama, Noboru N; O'Connor, Matthew M; Salomatov, Andrei A; Romashko, Darlene D; Thakur, Shalabh S; Mentes, Ahmet A; Hopkins, Julia F JF; Frampton, Garrett M GM; Albacker, Lee A LA; Kohlmann, Anna A; Roberts, Christopher C; Buck, Elizabeth E
Publication Date: 2022-05-03

Variant appearance in text: HER2: D769Y
PubMed Link: 35503682
Variant Present in the following documents:
  • Main text
  • 1531.pdf
View BVdb publication page



Molecular landscape of TP53 mutations in breast cancer and their utility for predicting the response to HER-targeted therapy in HER2 amplification-positive and HER2 mutation-positive amplification-negative patients.

Cancer Medicine
Liu, Binliang B; Yi, Zongbi Z; Guan, Yanfang Y; Ouyang, Quchang Q; Li, Chunxiao C; Guan, Xiuwen X; Lv, Dan D; Li, Lixi L; Zhai, Jingtong J; Qian, Haili H; Xu, Binghe B; Ma, Fei F; Zeng, Yixin Y
Publication Date: 2022-07

Variant appearance in text: ERBB2: 2305G>T; D769Y
PubMed Link: 35393784
Variant Present in the following documents:
  • CAM4-11-2767-s001.xlsx, sheet 1
View BVdb publication page



Retrospective Study on the Efficacy and Safety of Pyrotinib-Based Therapy for HER2-Positive Nonbreast Advanced Solid Tumors.

Journal Of Oncology
Wang, Jianzheng J; Zhang, Baiwen B; Cheng, Xiaojiao X; Li, Qingli Q; Lv, Huifang H; Nie, Caiyun C; Chen, Beibei B; Xu, Weifeng W; Zhao, Jing J; He, Yunduan Y; Tu, Shuiping S; Chen, Xiaobing X
Publication Date: 2022

Variant appearance in text: HER2: D769Y
PubMed Link: 35368895
Variant Present in the following documents:
  • JO2022-4233782.pdf
View BVdb publication page



Understanding the activating mechanism of the immune system against COVID-19 by Traditional Indian Medicine: Network pharmacology approach.

Advances In Protein Chemistry And Structural Biology
Thirumal Kumar, D D; Shree Devi, M S MS; Udhaya Kumar, S S; Sherlin, Annie A; Mathew, Aishwarya A; Lakshmipriya, M M; Sathiyarajeswaran, P P; Gnanasambandan, R R; Siva, R R; Magesh, R R; George Priya Doss, C C
Publication Date: 2022

Variant appearance in text: ERBB2: D769Y
PubMed Link: 35305722
Variant Present in the following documents:
  • mmc09-01-9780323992275.pdf
View BVdb publication page



Clinical and genomic features of Chinese lung cancer patients with germline mutations.

Nature Communications
Peng, Wenying W; Li, Bin B; Li, Jin J; Chang, Lianpeng L; Bai, Jing J; Yi, Yuting Y; Chen, Rongrong R; Zhang, Yanyan Y; Chen, Chen C; Pu, Xingxiang X; Jiang, Meilin M; Li, Jia J; Zhong, Rui R; Xu, Fang F; Chen, Bolin B; Xu, Li L; Wang, Ning N; Huan, Jiaojiao J; Dai, Pingping P; Guan, Yanfang Y; Yang, Ling L; Xia, Xuefeng X; Yi, Xin X; Wang, Jiayin J; Yu, Fenglei F; Wu, Lin L
Publication Date: 2022-03-10

Variant appearance in text: ERBB2: 2305G>T; D769Y
PubMed Link: 35273153
Variant Present in the following documents:
  • 41467_2022_28840_MOESM7_ESM.xlsx, sheet 1
View BVdb publication page



Custom multi‑tumor next‑generation sequencing panel for routine molecular diagnosis of solid tumors: Validation and results from three‑year clinical use.

International Journal Of Molecular Medicine
Chevrier, Sandy S; Brasselet, Astrid A; Carnet, Marion M; Chevriaux, Angélique A; Gibeaud, Anne A; Jourdain, Marine M; Mananet, Hugo H; Truntzer, Caroline C; Beltjens, Françoise F; Charon-Barra, Céline C; Arnould, Laurent L; Albuisson, Juliette J; Comte, Anthony A; Derangère, Valentin V; Goussot, Vincent V; Boidot, Romain R
Publication Date: 2022-05

Variant appearance in text: ERBB2: 2305G>T; Asp769Tyr
PubMed Link: 35244186
Variant Present in the following documents:
  • Supplementary_Data3.xlsx, sheet 1
View BVdb publication page



Systematic review and meta-analysis of genomic alterations in acral melanoma.

Pigment Cell & Melanoma Research
Broit, Natasa N; Johansson, Peter A PA; Rodgers, Chloe B CB; Walpole, Sebastian T ST; Hayward, Nicholas K NK; Pritchard, Antonia L AL
Publication Date: 2022-05

Variant appearance in text: ERBB2: D769Y
PubMed Link: 35229492
Variant Present in the following documents:
  • PCMR-35-369-s003.xlsx, sheet 12
View BVdb publication page



The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology.

Nature Cancer
Tamborero, David D; Dienstmann, Rodrigo R; Rachid, Maan Haj MH; Boekel, Jorrit J; Lopez-Fernandez, Adria A; Jonsson, Markus M; Razzak, Ali A; Braña, Irene I; De Petris, Luigi L; Yachnin, Jeffrey J; Baird, Richard D RD; Loriot, Yohann Y; Massard, Christophe C; Martin-Romano, Patricia P; Opdam, Frans F; Schlenk, Richard F RF; Vernieri, Claudio C; Masucci, Michele M; Villalobos, Xenia X; Chavarria, Elena E; , ; Balmaña, Judith J; Apolone, Giovanni G; Caldas, Carlos C; Bergh, Jonas J; Ernberg, Ingemar I; Fröhling, Stefan S; Garralda, Elena E; Karlsson, Claes C; Tabernero, Josep J; Voest, Emile E; Rodon, Jordi J; Lehtiö, Janne J
Publication Date: 2022-02

Variant appearance in text: ERBB2: Asp769Tyr
PubMed Link: 35221333
Variant Present in the following documents:
  • 43018_2022_332_MOESM3_ESM.xlsx, sheet 1
View BVdb publication page



Investigation of PALB2 Mutation and Correlation With Immunotherapy Biomarker in Chinese Non-Small Cell Lung Cancer Patients.

Frontiers In Oncology
Zhang, Jiexia J; Tang, Shuangfeng S; Zhang, Chunning C; Li, Mingyao M; Zheng, Yating Y; Hu, Xue X; Huang, Mengli M; Cheng, Xiangyang X
Publication Date: 2021

Variant appearance in text: ERBB2: 2305G>T; D769Y
PubMed Link: 35087742
Variant Present in the following documents:
  • Table_2.xlsx, sheet 1
View BVdb publication page



Role of ctDNA in Breast Cancer.

Cancers
Sant, Marta M; Bernat-Peguera, Adrià A; Felip, Eudald E; Margelí, Mireia M
Publication Date: 2022-01-09

Variant appearance in text: HER2: D769Y
PubMed Link: 35053474
Variant Present in the following documents:
  • Main text
  • cancers-14-00310.pdf
View BVdb publication page



Role of ctDNA in Breast Cancer.

Cancers
Sant, Marta M; Bernat-Peguera, Adrià A; Felip, Eudald E; Margelí, Mireia M
Publication Date: 2022-01-09

Variant appearance in text: HER2: D769Y
PubMed Link: 35053474
Variant Present in the following documents:
  • Main text
  • cancers-14-00310.pdf
View BVdb publication page



Multi-omic machine learning predictor of breast cancer therapy response.

Nature
Sammut, Stephen-John SJ; Crispin-Ortuzar, Mireia M; Chin, Suet-Feung SF; Provenzano, Elena E; Bardwell, Helen A HA; Ma, Wenxin W; Cope, Wei W; Dariush, Ali A; Dawson, Sarah-Jane SJ; Abraham, Jean E JE; Dunn, Janet J; Hiller, Louise L; Thomas, Jeremy J; Cameron, David A DA; Bartlett, John M S JMS; Hayward, Larry L; Pharoah, Paul D PD; Markowetz, Florian F; Rueda, Oscar M OM; Earl, Helena M HM; Caldas, Carlos C
Publication Date: 2022-01

Variant appearance in text: ERBB2: 2305G>T
PubMed Link: 34875674
Variant Present in the following documents:
  • 41586_2021_4278_MOESM4_ESM.xlsx, sheet 2
View BVdb publication page



Mutation analysis of a 10-gene panel for colorectal cancer in Huizhou, Guangdong Province of China.

The Journal Of International Medical Research
Li, Jun J; Sun, Aihua A; Zhong, Guofang G; He, Ying Y; Xiong, Hailin H; Yuan, Xia X
Publication Date: 2021-11

Variant appearance in text: ERBB2: 2305G>T
PubMed Link: 34851763
Variant Present in the following documents:
  • 10.1177_03000605211061040.pdf
View BVdb publication page



Afatinib combined with anlotinib in the treatment of lung adenocarcinoma patient with novel HER2 mutation: a case report and review of the literature.

World Journal Of Surgical Oncology
Xu, Huanhuan H; Liang, Qi Q; Xu, Xian X; Tan, Shanyue S; Wang, Sumeng S; Liu, Yiqian Y; Liu, Lingxiang L
Publication Date: 2021-11-18

Variant appearance in text: HER2: 2305G>T
PubMed Link: 34794435
Variant Present in the following documents:
  • Main text
  • 12957_2021_Article_2444.pdf
View BVdb publication page



TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer.

Cancer Medicine
Grote, Isabel I; Bartels, Stephan S; Kandt, Leonie L; Bollmann, Laura L; Christgen, Henriette H; Gronewold, Malte M; Raap, Mieke M; Lehmann, Ulrich U; Gluz, Oleg O; Nitz, Ulrike U; Kuemmel, Sherko S; Zu Eulenburg, Christine C; Braun, Michael M; Aktas, Bahriye B; Grischke, Eva-Maria EM; Schumacher, Claudia C; Luedtke-Heckenkamp, Kerstin K; Kates, Ronald R; Wuerstlein, Rachel R; Graeser, Monika M; Harbeck, Nadia N; Christgen, Matthias M; Kreipe, Hans H
Publication Date: 2021-12

Variant appearance in text: ERBB2: 2305G>T; D769Y
PubMed Link: 34779146
Variant Present in the following documents:
  • CAM4-10-8581-s002.xlsx, sheet 1
View BVdb publication page



TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer.

Cancer Medicine
Grote, Isabel I; Bartels, Stephan S; Kandt, Leonie L; Bollmann, Laura L; Christgen, Henriette H; Gronewold, Malte M; Raap, Mieke M; Lehmann, Ulrich U; Gluz, Oleg O; Nitz, Ulrike U; Kuemmel, Sherko S; Zu Eulenburg, Christine C; Braun, Michael M; Aktas, Bahriye B; Grischke, Eva-Maria EM; Schumacher, Claudia C; Luedtke-Heckenkamp, Kerstin K; Kates, Ronald R; Wuerstlein, Rachel R; Graeser, Monika M; Harbeck, Nadia N; Christgen, Matthias M; Kreipe, Hans H
Publication Date: 2021-12

Variant appearance in text: ERBB2: 2305G>T; D769Y
PubMed Link: 34779146
Variant Present in the following documents:
  • CAM4-10-8581-s002.xlsx, sheet 1
View BVdb publication page



Targeted Therapy of Papillary Thyroid Cancer: A Comprehensive Genomic Analysis.

Frontiers In Endocrinology
Hescheler, Daniel A DA; Riemann, Burkhard B; Hartmann, Milan J M MJM; Michel, Maximilian M; Faust, Michael M; Bruns, Christiane J CJ; Alakus, Hakan H; Chiapponi, Costanza C
Publication Date: 2021

Variant appearance in text: ERBB2: D769Y
PubMed Link: 34630336
Variant Present in the following documents:
  • Table_1.xlsx, sheet 2
View BVdb publication page



Genomic Profiling Reveals the Molecular Landscape of Gastrointestinal Tract Cancers in Chinese Patients.

Frontiers In Genetics
Zhu, Chunrong C; Zhu, Liangjun L; Gu, Yanhong Y; Liu, Ping P; Tong, Xiaoling X; Wu, Guozhong G; Zhu, Wenyu W; Shen, Wenxiang W; Bao, Hua H; Ma, Xiangyuan X; Yu, Ruoying R; Wu, Xue X; Zhu, Dongqin D; Shu, Yongqian Y; Feng, Jifeng J
Publication Date: 2021

Variant appearance in text: ERBB2: D769Y
PubMed Link: 34594355
Variant Present in the following documents:
  • Table_2.xlsx, sheet 1
View BVdb publication page



Next-Generation Sequencing-Directed Therapy in Patients with Metastatic Breast Cancer in Routine Clinical Practice.

Cancers
Bruzas, Simona S; Kuemmel, Sherko S; Harrach, Hakima H; Breit, Elisabeth E; Ataseven, Beyhan B; Traut, Alexander A; Rüland, Anna A; Kostara, Athina A; Chiari, Ouafaa O; Dittmer-Grabowski, Christine C; Reinisch, Mattea M
Publication Date: 2021-09-11

Variant appearance in text: ERBB2: D769Y
PubMed Link: 34572791
Variant Present in the following documents:
  • Main text
  • cancers-13-04564.pdf
View BVdb publication page



Dissecting the biological heterogeneity of HER2-positive breast cancer.

Breast (Edinburgh, Scotland)
Schettini, Francesco F; Prat, Aleix A
Publication Date: 2021-10

Variant appearance in text: HER2: D769Y
PubMed Link: 34392185
Variant Present in the following documents:
  • Main text
  • main.pdf
View BVdb publication page